Biotech

All Articles

Vaderis' rare blood vessel condition drug reduces nosebleeds

.Vaderis Therapies' target to cultivate the 1st medicine striven exclusively at a certain rare capil...

Navigator increases $100M to cultivate brand new autoimmune pipeline

.Navigator Medicines has furnished itself with $100 million in collection A funds as the younger bio...

Duality looks for cash money for ADC trials as IPO surge infects Asia

.China's Duality Biotherapeutics has submitted (PDF) documents for a Hong Kong IPO, finding a secret...

YolTech offers China legal rights to gene editing and enhancing treatment for $29M

.4 months after Mandarin gene modifying company YolTech Rehabs took its cholesterol disease-focused ...

Addex stock rises after Indivior offers up to $300M for compound

.Indivior is actually getting a small molecule allosteric modulator designed to treat element make u...

Molecular Allies adjusts AML trial over 'suboptimal exposure'

.Molecular Partners has recognized "suboptimal exposure" to its tetra-specific T-cell engager as the...

Despite combined market, an equity capital revival might be being available in Europe: PitchBook

.While the biotech financial investment performance in Europe has slowed down relatively following a...

8 months after a $213M fundraise, gene editor Volume creates cuts

.After bring up $213 million in 2023-- one of the year's most extensive exclusive biotech shots-- To...

BioMarin builds director team with biotech veterinarians-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of considerable management hirings, shootings...

Biopharma Q2 VC struck highest level because '22, while M&ampA reduced

.Financial backing financing in to biopharma rose to $9.2 billion all over 215 handle the 2nd one-fo...